Finance

Lists
Q3 2026 earnings • released • EPS beat +17.95%
See results
DFTX:NASDAQ
Definium Therapeutics Inc
$34.44
-2.67%
(-0.94) 1D
Nov 10, 12:50:41 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for DFTX...
Open
$34.45
High
$35.97
Low
$33.78
Mkt. cap
4.63B
Avg. vol.
1.92M
Volume
566.67K
52-wk high
$49.70
52-wk low
$14.62
EPS
-$3.43
Beta
2.23
Shares outstanding
134.37M
No. of employees
106
Open
$34.45
High
$35.97
Low
$33.78
Mkt. cap
4.63B
Avg. vol.
1.92M
Volume
566.67K
52-wk high
$49.70
52-wk low
$14.62
EPS
-$3.43
Beta
2.23
Shares outstanding
134.37M
No. of employees
106
News stories
From web sources and news partners
Profile
Definium Therapeutics, Inc., formerly known as MindMed, is a New York-based biotechnology company that is currently developing clinical and therapeutic applications for psychedelic and, more broadly, psychoplastogenic drugs. Wikipedia
About Definium Therapeutics Inc
CEORobert Barrow
Employees106
Founded2010
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitedefiniumtx.com
Analyst ratings
Based on 15 analysts giving stock ratings to DFTX in the past 3 months
Strong buy
Buy
15
Hold
0
Sell
0
12-month forecast
Based on 15 Wall Street analysts offering 12 month price targets for DFTX in the last 3 months.
Highest
Current $34.44
$91.00 (+164.19%)
Average
$73.64 (+113.79%)
Lowest
$55.00 (+59.67%)
Analyst
Recommendation
Action
Price target
Projected
Date
Tessa Romero
J.P. Morgan
Buy
Maintained
-
-
11/09/2026
Jay Olson
Oppenheimer
Buy
Maintained
$75.00
+117.7%
11/10/2026
Ami Fadia
Needham
Buy
Reiterated
$66.00
+91.6%
11/10/2026
Sumant Kulkarni
Canaccord Genuity
Buy
Reiterated
$78.00
+126.4%
11/10/2026
David Amsellem
Piper Sandler
Buy
Reiterated
$75.00
+117.7%
11/10/2026
Tazeen Ahmad
Bank of America Securities
Buy
Reiterated
$91.00
+164.2%
11/09/2026
Brian Abrahams
RBC Capital
Buy
Reiterated
$70.00
+103.2%
11/09/2026
Patrick Trucchio
H.C. Wainwright
Buy
Reiterated
$70.00
+103.2%
11/09/2026
Francois Brisebois
LifeSci Capital
Buy
Maintained
$78.00
+126.4%
09/19/2026
Michael Okunewitch
Maxim Group
Buy
Maintained
$55.00
+59.7%
09/15/2026
Paul Matteis
Stifel Nicolaus
Buy
Maintained
$67.00
+94.5%
09/15/2026
Justin Walsh
JonesTrading
Buy
Reiterated
$90.00
+161.3%
09/15/2026
Christopher Chen
Robert W. Baird
Buy
Maintained
$79.00
+129.4%
09/15/2026
Benjamin Burnett
Wells Fargo
Buy
Maintained
$72.00
+109%
08/31/2026
Andrew Tsai
Jefferies
Buy
Maintained
$65.00
+88.7%
08/13/2026
Unknown Analyst
Evercore ISI
Buy
Maintained
$53.00
+53.9%
08/10/2026
Gavin Clark-Gartner
Evercore ISI
Buy
Maintained
$26.00
-24.5%
03/02/2026
Rudy Li
Wolfe Research
Buy
Initiated
$25.00
-27.4%
02/23/2026
Last report
Nov 9, 2026
Fiscal period
Q3 2026
-$0.46 / -$0.56
+17.95%beat
Revenue / Est. (USD)
- / 0.00
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
30.98M
33.52M
41.48M
48.66M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
14.69M
14.06M
17.74M
26.41M
Operating expense
45.67M
47.58M
59.22M
75.08M
Total operating expenses
45.67M
47.58M
59.22M
75.08M
Operating income
-45.67M
-47.58M
-59.22M
-75.08M
Other non operating income
-22.54M
-5.06M
-20.05M
-86.23M
EBT including unusual items
-67.26M
-50.44M
-77.10M
-158.99M
EBT excluding unusual items
-67.26M
-50.44M
-77.10M
-158.99M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-67.26M
-50.44M
-77.10M
-158.99M
Net profit margin
-
-
-
-
Earnings per share
-0.78
-
-
-1.44
Interest and investment income
2.26M
3.49M
3.46M
3.59M
Interest expense
-1.27M
-1.27M
-1.24M
-1.23M
Net interest expenses
988.00K
2.22M
2.21M
2.35M
Depreciation and amortization charges
-
-
-
-
EBITDA
-45.66M
-47.57M
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps